You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: October 2021 to March 2024

AbstractFullPdf
Oct 2021391391112
Nov 2021547549190
Dec 202121021069
Jan 202224225563
Feb 20229610146
Mar 2022747425
Apr 2022727632
May 2022777732
Jun 2022808032
Jul 2022767723
Aug 2022919426
Sep 202210610741
Oct 2022878744
Nov 2022313339
Dec 2022434321
Jan 2023787824
Feb 2023676714
Mar 2023525416
Apr 2023464629
May 2023424224
Jun 2023444436
Jul 2023585824
Aug 2023656533
Sep 2023838325
Oct 2023363638
Nov 2023595923
Dec 2023454514
Jan 2024394013
Feb 2024464622
Mar 2024454562
Total302830621192